Apollon Wealth Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.07M | Sell |
15,273
-602
| -4% | -$42.1K | 0.02% | 534 |
|
|
2025
Q1 | $1.17M | Buy |
15,875
+79
| +0.5% | +$5.81K | 0.03% | 465 |
|
|
2024
Q4 | $1.03M | Buy |
15,796
+347
| +2% | +$22.7K | 0.02% | 505 |
|
|
2024
Q3 | $1.2M | Sell |
15,449
-126
| -0.8% | -$9.82K | 0.03% | 425 |
|
|
2024
Q2 | $1.21M | Sell |
15,575
-100
| -0.6% | -$7.8K | 0.04% | 408 |
|
|
2024
Q1 | $1.06M | Sell |
15,675
-11,295
| -42% | -$765K | 0.03% | 452 |
|
|
2023
Q4 | $1.82M | Buy |
26,970
+4,499
| +20% | +$303K | 0.06% | 287 |
|
|
2023
Q3 | $1.52M | Buy |
22,471
+6,575
| +41% | +$445K | 0.08% | 256 |
|
|
2023
Q2 | $1.14M | Sell |
15,896
-1,885
| -11% | -$135K | 0.05% | 355 |
|
|
2023
Q1 | $1.23M | Sell |
17,781
-3,064
| -15% | -$213K | 0.08% | 275 |
|
|
2022
Q4 | $1.41M | Sell |
20,845
-159
| -0.8% | -$10.8K | 0.1% | 214 |
|
|
2022
Q3 | $1.15M | Buy |
21,004
+8,969
| +75% | +$492K | 0.09% | 219 |
|
|
2022
Q2 | $795K | Buy |
12,035
+6,333
| +111% | +$418K | 0.07% | 315 |
|
|
2022
Q1 | $378K | Sell |
5,702
-4,485
| -44% | -$297K | 0.03% | 533 |
|
|
2021
Q4 | $593K | Buy |
10,187
+6,401
| +169% | +$373K | 0.04% | 418 |
|
|
2021
Q3 | $227K | Buy |
+3,786
| New | +$227K | 0.03% | 410 |
|
|
2020
Q3 | – | Sell |
-481
| Closed | -$25K | – | 199 |
|
|
2020
Q2 | $25K | Buy |
+481
| New | +$25K | 0.01% | 331 |
|